Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2010
10/28/2010CA2759241A1 Novel anti-inflammatory agents
10/28/2010CA2758838A1 Heterocyclic antiviral compounds
10/27/2010EP2242493A1 Derivatives of gefitinib
10/27/2010EP1539710B1 Heterocyclic derivatives
10/27/2010CN1993356B Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
10/27/2010CN1726195B Process for the preparation of pyrimidine compounds
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874024A 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
10/27/2010CN101874023A Alkylthio pyrimidines as CRTH2 antagonists
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/27/2010CN101027309B Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
10/26/2010USRE41894 Hepatitis C inhibitor tri-peptides
10/26/2010US7820861 chemical intermediate for a sulfonanilide of 4,6-dimethoxypyrmidine derivative herbicide
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820818 Inhibitors of cathepsin K; inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors; 4-Cyclopentylamino-5-(4-phenyl-but-1-ynyl)-pyrimidine-2-carbonitrile; 5-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-prop-1-ynyl]-4-(2,2-dimethyl-propylamino)-pyrimidine-2-carbonitrile
10/26/2010US7820817 substituted piperazine compounds that are useful modulators of muscarinic receptors; 1-(5-bicyclo[2.2.1]hept-2-enylmethyl)-4-(3-nitro-2-pyridyl)-piperazine; treatment of COPD, asthma, urinary incontinence, glaucoma, Alzheimer's (AchE inhibitors), and pain
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820704 Substituted heteroaryl derivatives, compositions, and methods of use
10/26/2010US7820687 inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, diabetes, autoimmune diseases, tumor metastasis and myocardial ischemia; improved bioavailability; 2-(2-(diethylamino)-5-(N-isopropylmethylsulfonamido)pyrimidin-4-ylamino)-3-(4-(pyrrolidine-1-carbonyloxy)phenyl)propanoic acid
10/26/2010US7820679 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent
10/26/2010US7820664 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/26/2010US7820660 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/26/2010US7820654 such as 1-[2-(3-Chloro-4-methoxy-phenylamino)-6-phenyl-pyrimidin-4-yl]-piperidin-4-ol for treating atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by low expression of Perlecan
10/26/2010US7820649 2-[2-(3-Chlorophenyl)-4-oxo-6-perhydro-1,4-diazepin-1-yl-4H-quinazolin-3-yl]-N-isopropylacetamide; hypothalamo-pituitary-adrenal (HPA) axis stress relieving agent; adrenocorticotropic hormone (ACTH)/ glucocorticoid antagonist; psychological and bipolar disorders, schizophrenia, psychosis, hyperactivity
10/26/2010US7820647 e.g. 1-[4-chloro-6-(2,2,2-trifluoro-1-methylethylamino)-5-(2,4,6-trifluorophenyl)pyrimidin-2-yl]-pyrrolidin-2-one; controlling phytopathogenic harmful fungi, such as Ascomycetes, Deuteromycetes, Oomycetes and Basidiomycetes; materials, plants, soil, seeds;
10/26/2010US7820641 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
10/26/2010US7820631 For prophylaxis and therapy of viral infection for example by varicella zoster virus (VZV)
10/26/2010US7820159 Using epidermal growth factor receptor as tool in identifying modulators for prevention and treatment of cell proliferative disorders
10/26/2010CA2598725C Fused aromatic compounds having anti-diabetic activity
10/26/2010CA2289408C Corrosion inhibitor compositions
10/21/2010WO2010119050A1 New rac1 inhibitors as potential pharmacological agents for heart failure treatment
10/21/2010WO2010118986A1 Fluoro substituted pyrimidine compounds as jak3 inhibitors
10/21/2010WO2009126515A8 Compounds and compositions as protein kinase inhibitors
10/21/2010US20100267949 Method of Synthesizing 6,7-Substituted 4-Anilino Quinazoline
10/21/2010US20100267755 Pyrimidine derivatives
10/21/2010US20100267752 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/21/2010US20100267728 3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
10/21/2010US20100267718 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267676 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/2010US20100267669 Heterocyclic cetp inhibitors
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100266714 P2x3 receptor antagonists for treatment of pain
10/21/2010CA2758614A1 Fluoro substituted pyrimidine compounds as jak3 inhibitors
10/20/2010EP2241556A1 Method for the preparation of capecitabine and intermediates used in said method
10/20/2010EP2241555A1 New RAC1 inhibitors as potential pharmacological agents for heart failure treatment
10/20/2010EP2240470A2 Improved and novel process for the preparation of bosentan
10/20/2010EP2240455A1 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
10/20/2010EP2240454A1 Mesoionic pesticides
10/20/2010EP2102173B1 Pyrimidyl derivatives as protein kinase inhibitors
10/20/2010EP2049491B1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101863844A Synthesis method of 6,7-substituted-4-aniline quinazoline
10/20/2010CN101863843A Method for producing dihydroquinazolines
10/20/2010CN101863842A Entecavir midbodies and synthesis method
10/20/2010CN101863841A Substituted tetracycline compounds
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816528 Preparation of aminopyrimidine compounds
10/19/2010US7816527 Quinazoline-containing kits for labeling aldehyde or ketone moieties
10/19/2010US7816526 Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
10/19/2010US7816523 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist; migraine; nerve system disorders
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816354 4'-(2-Oxo-5-(R)-phenyl-oxazolidin-3-ylmethyl) biphenyl-3-carboxylic acid (2-dimethylamino-ethyl)-amide, usedd for the treatment or prevention of neurological and psychiatric disorders
10/19/2010US7816353 P70S6 kinase modulators and method of use
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/14/2010WO2010117435A2 No-carrier-added nucleophilic [f-18] fluorination of aromatic compounds
10/14/2010WO2010117064A1 Compound having hetero ring skeleton, and process for producing optically active compound using the aforementioned compound as asymmetric catalyst
10/14/2010WO2010115950A2 Process for the preparation of pyrimidine derivatives
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/14/2010WO2010082072A8 Process for the preparation of rosuvastatin salts
10/14/2010WO2009124013A8 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/14/2010WO2009044018A9 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
10/14/2010US20100261900 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10/14/2010US20100261741 Quinazolinone T-Type Calcium Channel Antagonists
10/14/2010US20100261740 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
10/14/2010US20100261738 Novel polymorphs of erlotinib hydrochloride and method of preparation
10/14/2010US20100261722 Hiv inhibiting 5, 6-substituted pyrimidines
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010DE102009015070A1 New phenyl-pyrimidin-2-yl-amine compounds are tyrosine kinase 2 inhibitors useful for treating e.g. rheumatoid arthritis, Crohn's disease, asthma, multiple sclerosis, adult respiratory distress syndrome, allergic alveolitis and uveitis
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2758072A1 Macrocyclic serine protease inhibitors
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
10/13/2010EP2239260A1 Novel compounds with antibacterial activity
10/13/2010EP2239257A2 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
10/13/2010EP2239256A1 Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
10/13/2010EP2239255A1 Compound for organic electroluminescent device and organic electroluminescent device using the same
10/13/2010EP2238119A1 Quinazolines and related heterocyclic compounds, and their therapeutic use
10/13/2010EP2238118A1 Method of synthesis of bosentan, its polymorphic forms and its salts
10/13/2010EP2237669A2 Chemical compounds
10/13/2010EP1204642B1 Fungicides
10/13/2010CN1972918B Pyrimidine derivatives
10/13/2010CN101861313A Phenyl amino pyrimidine compounds and uses thereof
10/13/2010CN101857588A 4-aromatic aminoquinazoline derivative and purpose thereof
10/13/2010CN101857573A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/13/2010CN101857572A 4-aromatic amino pyrimidine derivative and application thereof
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 427